Evaluation of causes of increased incidence of cervical cancer in Slovenia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 117, Issue 2, 2004, Pages 213-221

  Smrkolj, Špela ^a   Rakar, Stelio ^a   Možina, Andrej ^a   Eržen, Mojca ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Causes of increase; Cervical cancer screening; Incidence; Questionnaire

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CYTOLOGY; DEMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK FACTOR; SLOVENIA; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 8444237401     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.06.002     Document Type: Article

References (45)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press; 2001.
2. Boyle P. Global burden of cancer. Lancet. 349(Suppl II):1997;23-26
3. Miller A.B., Nazeer S., Fonn S. Report on consensus conference on cervical cancer screening and management. Int. J. Cancer. 86:2000;440-447
4. Syrjänen K. Early detection of CIN and HPV: prevention of cervical cancer. In: Syrjänen K, Syrjänen S, editors. Papillomavirus infections in human pathology. New York: Wiley; 2000. p. 167-88 [Chapter 7].
5. Syrjänen K, Syrjänen S. Papillomavirus infections in human pathology. New York: Wiley; 2000. p. 1-615.
6. Miller A.B., Chamberlain J., Day N.E., Hakama M., Prorok P.C. Report on a workshop of the UICC project on evaluation of screening for cancer. Int. J. Cancer. 46:1990;761-769
7. Franco E, Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science; 1997. p. 1-628.
8. Hakama M. Screening for cervical cancer: experience from the Nordic Countries. In: Franco E, Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science; 1997. p. 190-9.
9. Michalas S.P. The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 90:2000;135-138
10. Austin L.T., Ahmad F., McNally M.J., Stewart D.E. Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Women's Health Issues. 12:2002;122-128
11. Boon M.E., de Graaff-Guilloud J.C., Rietveld W.J., Wijsman-Grootendorst A. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience. Cytopathology. 1:1990;201-210
12. Brinton L.A. Epidemiology of cervical cancer. Overview. IARC Sci. Publ. 119:1992;3-23
13. La Vecchia C., Levi F., Franceschi S. Screening for cancer. 1995: an update. Ann. Oncol. 6:1995;537-541
14. Cox B., Borman B. Cervical cancer in New Zealand: national and regional trends. N. Z. Med. J. 107:1994;323-326
15. Fitch M.I., Greenberg M. Exploring the barriers to cervical screening in an urban Canadian setting. Cancer Nurs. 21:1998;441-449
16. Wise J. Improvements needed in cervical screening in England. Br Med J. 316:1998;1261
17. Anttila A., Pukkala E. Effect of organised screening on cervical cancer incidence and mortality in Finland. 1963-1995: recent increase in cervical cancer incidence. Int. J. Cancer. 83:1999;59-65
18. Kovaèiè J. Evaluation of mass screening for cervical cancer in Ljubljana region. Tumori. 62(3):1976;343-349
19. Kovaèiè J, Hvalec Š, Leviènik A, Debevec M, Eržen M. Fifty years of gynecologic cytology at the Department of Obstetrics and Gynecology in Ljubljana. In: Eržen M, editor. Book of proceedings, Training of cytotechnologists and cytopathologists in cervical cancer screening in 21st century: new approaches to vocational training and continuous professional education. Ljubljana 14 March 2003. Ljubljana: The Slovenian Society of Gynecological Oncology, Colposcopy and Cervical Cytopathology; 2003. p. 22-30.
20. Pompe Kirn V., Vršèaj Uršiè M., Kovaèiè J., Primic Žakelj M. Epidemiological evaluation of early detection of cervical cancer in Slovenia till. Eur. J. Gynaecol. Oncol. 7(3):1986;147-151
21. Pompe Kirn V.P., Kovaèiè J., Primic Žakelj M. Epidemiological evaluation of cervical cancer screening in Slovenia up to 1986. Eur. J. Gynaecol. Oncol. 13:1992;75-82
22. Primic Žakelj M. Epidemiology of cervical cancer in Slovenia and "ZORA" programme. In: Eržen M, editor. Book of proceedings, Ljubljana 14 March 2003. Training of cytotechnologists and cytopathologists in cervical cancer screening in 21st century: new approaches to vocational training and continuous professional education. Ljubljana: The Slovenian Society of Gynecological Oncology, Colposcopy and Cervical Cytopathology; 2003. p. 19-21.
23. Stafl A., Wilbanks G.D. An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet. Gynecol. 77:1991;313-314
24. Creasman W.T. Modification of the staging for stage I vulvar and stage I cervical cancer. Int. J. Gynecol. Obstet. 50:1995;215-216
25. Tavassoli FA, Devilee P, editors. WHO classification of tumours. Pathology and genetics oftumours of the breast and female genital organs. Lyon, France: IARC Press, International Agency of Research on Cancer; 2003. p. 259-77.
26. Wright TC, Ferenzy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, editor. Blausstein's pathology of the female genital tract, 4th ed. New York: Springer-Verlag; 1994. p. 284-98.
27. Eržen M, Rakar S. Prognostic factors in microinvasive carcinoma of the uterine cervix. In: Bösze P. (Ed.). CME J Gynecol Oncol 2001;6:307-27 [Invited Review].
28. Syrjänen K., Erzen M., Syrjänen S. Cervical cancer control by organised screening. Issues to be considered in designing a national programme. Kolposkopia. 2:2001;95-116
29. Nanda K., McCroy D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities. A systematic review. Ann. Intern. Med. 132:2000;810-819
30. Fahey M.T., Irwig L., Macaskill P. Meta-analysisof Pap test accuracy. Am. J. Epidemiol. 141:1995;680-689
31. Lorincz A.T. Screening for cervical cancer: new alternatives and research. Salud Publica Mex. 45(Suppl 3):2003;S376-S387
32. Franco E.L., Duarte-Franco E., Ferenczy A. Prospects for controlling cervical cancer at the turn of the century. Salud Publica Mex. 45(Suppl 3):2003;S367-S375
33. Coldman A., Phillips N., Kan L., Matisic J., Benedet L., Towers L. Risk of invasive cervical cancer after three consecutive negative Pap smears. J. Med. Screen. 10(4):2003;196-200
34. Griffin NR, Wells M. Premalignant and malignant glandular lesions of the cervix. In: Fox H, Wells M, editors. Haines and Taylor obstetrical and gynaecological pathology, 4th ed. New York: Churchill Livingstone; 1995. p. 323-43.
35. Anderson M.C. Glandular lesions of the cervix: diagnostic and therapeutic dilemmas. Bailliere Clin. Obstet. Gyn. 9:1995;105-119
36. Eržen M., Možina A., Bertole J., Syrjänen K. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 101(2):2002;185-191
37. Syrjänen K. HPV and cervical adenocarcinoma. In: Syrjänen K, Syrjänen S, editors. Papillomavirus infections in human pathology. New York: Wiley; 2000. p. 189-206 [Chapter 8].
38. Renshaw A.A., Mody D.R., Lozano R.L., Volk E.E., Walsh M.K., Davey D.D., et al. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions. Arch. Pathol. Lab. Med. 128:2004;153-157
39. Wilbur D.C. Endocervical glandular atypia: a "new" problem for the cytologist. Diagn Cytopathol. 13:1995;463-469
40. Brinton L.A., Herrero R., Reeves W.C., Debritton R.C., Gaitan E., Tenorio F. Risk factors for cervical cancer by histology. Gynecol. Oncol. 51:1993;301-306
41. Mitchell H., Medley G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br. J. Cancer. 71:1995;894-897
42. Östör A.G. Early invasive adenocarcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 19:2000;29-38
43. Pohar-Marinèek Ž., Pogaènik A. Cytopathology in Slovenia. Cytopathology. 15:2004;53-57
44. Wain G.V., Farnsworth A., Hacker N.F. Cervical carcinoma after negative Pap smears: evidence against rapid-onset cancers. Int. J. Gynecol. Cancer. 2(6):1992;318-322
45. Hildesheim A., Hadjimichael O., Schwartz P.E., Wheeler C.M., Barnes W., Lowell D.M., et al. Risk factors for rapid-onset cervical cancer. Am. J. Obstet. Gynecol. 180:1999;571-577